SLI
2.132,65
PKT
+1,64
PKT
+0,08
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.11.12 | Sonova neutral | UBS AG | |
| 14.11.12 | Sonova overweight | J.P. Morgan Cazenove | |
| 14.11.12 | Geberit halten | Öko Invest | |
| 14.11.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 14.11.12 | Swiss Life buy | Nomura | |
| 14.11.12 | Nestlé overweight | Morgan Stanley | |
| 14.11.12 | Julius Bär buy | Sarasin Research | |
| 14.11.12 | Julius Bär reduce | Vontobel Research | |
| 14.11.12 | UBS overweight | Morgan Stanley | |
| 14.11.12 | Sonova buy | Vontobel Research | |
| 13.11.12 | Swiss Life buy | Vontobel Research | |
| 13.11.12 | Swisscom hold | Vontobel Research | |
| 13.11.12 | Sonova buy | Vontobel Research | |
| 13.11.12 | Swiss Life buy | Sarasin Research | |
| 13.11.12 | Sonova neutral | Sarasin Research | |
| 12.11.12 | Novartis outperform | Credit Suisse Group | |
| 12.11.12 | Holcim hold | Deutsche Bank AG | |
| 12.11.12 | Swisscom neutral | Nomura | |
| 12.11.12 | Richemont buy | Nomura | |
| 12.11.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 12.11.12 | Richemont buy | Vontobel Research | |
| 12.11.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 12.11.12 | Julius Bär reduce | Vontobel Research | |
| 12.11.12 | UBS outperform | Macquarie Research | |
| 09.11.12 | Swiss Re kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 09.11.12 | Swiss Re buy | UBS AG | |
| 09.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 09.11.12 | Zurich Insurance neutral | Exane-BNP Paribas SA | |
| 09.11.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 09.11.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 09.11.12 | Swiss Re reduce | Nomura | |
| 09.11.12 | UBS outperform | Cheuvreux SA | |
| 09.11.12 | Swisscom neutral | Sarasin Research | |
| 09.11.12 | Richemont neutral | Sarasin Research | |
| 09.11.12 | Swisscom hold | Vontobel Research | |
| 09.11.12 | Swiss Re buy | Vontobel Research | |
| 09.11.12 | Richemont buy | Vontobel Research | |
| 08.11.12 | UBS overweight | HSBC | |
| 08.11.12 | UBS neutral | HSBC | |
| 08.11.12 | Holcim outperform | Exane-BNP Paribas SA |